Kuano London
About Kuano London
Kuano London
Kuano uses quantum simulation and quantum-inspired AI for enzyme drug design with programs in epigenetics, protein degradation, and infectious disease. The London company develops quantum-enhanced drug discovery platforms. Kuano combines quantum algorithms with machine learning to accelerate enzyme engineering and drug design, targeting challenging therapeutic areas where conventional computational methods provide limited insights.
Company Information
- Founded: 2020
- Country: United Kingdom
- Website: https://kuano.ai
- Categories: quantum chemistry, drug discovery
Related Companies
Explore other quantum computing companies in similar categories or regions.
Company Information
⚠️ Important Disclaimer
Information for Educational Purposes Only: All information about Kuano London is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Warranties: While we strive for accuracy, Quantum Zeitgeist makes no warranties regarding the accuracy, completeness, or timeliness of company information. The quantum technology industry evolves rapidly, and information may become outdated.
No Endorsement: Inclusion in Quantum Navigator does not constitute an endorsement, recommendation, or verification of Kuano London's claims, technology, or business viability.
Do Your Own Research: Always conduct independent due diligence and consult qualified professionals (financial advisors, lawyers, etc.) before making investment, business, or career decisions.
For more information, see our Terms of Service and Privacy Policy.